Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Change in Receivables: 2020-2021

Historic Change in Receivables for Janux Therapeutics (JANX) over the last 2 years, with Dec 2021 value amounting to -$8.0 million.

  • Janux Therapeutics' Change in Receivables rose 1030.80% to $7.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $7.5 million, marking a year-over-year change of. This contributed to the annual value of -$8.0 million for FY2021, which is 200.00% down from last year.
  • Per Janux Therapeutics' latest filing, its Change in Receivables stood at -$8.0 million for FY2021, which was down 200.00% from $8.0 million recorded in FY2020.
  • Over the past 5 years, Janux Therapeutics' Change in Receivables peaked at $8.0 million during FY2020, and registered a low of -$8.0 million during FY2021.
  • For the 2-year period, Janux Therapeutics' Change in Receivables averaged around $0, with its median value being $0 (2020).
  • Data for Janux Therapeutics' Change in Receivables shows a maximum YoY plummeted of 200.00% (in 2021) over the last 5 years.
  • Yearly analysis of 2 years shows Janux Therapeutics' Change in Receivables stood at $8.0 million in 2020, then plummeted by 200.00% to -$8.0 million in 2021.